NCT05414305View on ClinicalTrials.gov

The Female Microbiome in Patients Undergoing Bladder Instillation Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Interstitial CystitisBladder Pain SyndromeMicrobial Colonization
Interventions
DRUG

Heparin & Alkalinized Lidocaine Bladder Instillation

Bladder instillation instilled via catheter and to dwell for minimum of 30 minutes prior to spontaneous void

Trial Locations (1)

20889

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors
collaborator

US Army Medical Research Institute of Infectious Diseases

FED

lead

Walter Reed National Military Medical Center

FED

NCT05414305 - The Female Microbiome in Patients Undergoing Bladder Instillation Therapy | Biotech Hunter | Biotech Hunter